Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03655262 · ClinicalTrials.gov registry record · NA
Treating Phobia With Multivoxel Neuro-reinforcement
A NA study of Phobia, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT03655262 is a NA study of Phobia that has completed, run by University of California, Los Angeles. The registered enrollment target is 23 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03655262, a NA study of Phobia, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
Specific phobias and other anxiety disorders represent a major mental health problem, and present a significant challenge to researchers because effective treatment usually involves repeated exposure to feared stimuli, and the high levels of associated distress can lead to termination of treatment. Recent advances in computational functional magnetic resonance imaging (fMRI) provide a method by which individuals may be unconsciously exposed to fearful stimuli, leading to effective fear reduction while eliminating a primary cause of attrition. The objective of the current study is to use the novel approach of neuro-reinforcement based on decoded fMRI information to reduce fear responses to fearful stimuli (e.g., spiders, heights) in individuals with phobias, directly and unconsciously in the brain, without repeatedly exposing participants to their feared stimuli. Participants will be randomized into one of three groups of varying neuro-reinforcement sessions (1, 3, or 5). They will complete tests of subjective fear and directed attention while being scanned by fMRI to measure engagement of amygdala activity to fearful stimuli as well as measured through other indicators of fear such as skin conductance response.
Conditions Studied
Interventions
- BEHAVIORAL Unconscious Neuro-reinforcement
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03655262
The ClinicalTrials.gov registry entry for NCT03655262 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Phobia appearing as the primary indexed condition, and to 1 intervention - of which Unconscious Neuro-reinforcement is the first listed.
NCT03655262 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03655262 about?
NCT03655262 is a clinical study titled "Treating Phobia With Multivoxel Neuro-reinforcement". Specific phobias and other anxiety disorders represent a major mental health problem, and present a significant challenge to researchers because effective treatment usually involves repeated exposure to feared stimuli, and the high levels of associated distress can lead to termination of treatment. ...
What is the current status of trial NCT03655262?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2018-10-01. Estimated completion is 2022-06-30.
What conditions does trial NCT03655262 study?
This clinical trial studies the following conditions: Phobia.
What interventions are being tested in trial NCT03655262?
The interventions under investigation include: Unconscious Neuro-reinforcement (BEHAVIORAL).
Who is sponsoring clinical trial NCT03655262?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03655262 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Phobia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.